ALPHYN BIOLOGICS Trademark

Trademark Overview


On Thursday, October 1, 2020, a trademark application was filed for ALPHYN BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the ALPHYN BIOLOGICS trademark a serial number of 90229999. The federal status of this trademark filing is REGISTERED as of Tuesday, June 29, 2021. This trademark is owned by Alphyn Biologics, LLC. The ALPHYN BIOLOGICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development
alphyn biologics

General Information


Serial Number90229999
Word MarkALPHYN BIOLOGICS
Filing DateThursday, October 1, 2020
Status700 - REGISTERED
Status DateTuesday, June 29, 2021
Registration Number6401331
Registration DateTuesday, June 29, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements


Description of MarkThe mark consists of a drawing of an Alphyn with the words "Alphyn Biologics" beneath the drawing and in a stylized font. A horizontal line is between the words "Alphyn" and "Biologics".
Disclaimer with Predetermined Text"BIOLOGICS"
Goods and ServicesResearch and development of drugs and medicines for the treatment of infections, lung diseases, and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on lung diseases, skin diseases, infections, and cancer; Pharmaceutical products testing, analysis, research, and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 16, 2020
Primary Code042
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History


Party NameALPHYN BIOLOGICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressANNAPOLIS, MD 21403

Party NameAlphyn Biologics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAnnapolis, MD 21403

Party NameAlphyn Biologics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAnnapolis, MD 21403

Party NameAlphyn Biologics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAnnapolis, MD 21403

Trademark Events


Event DateEvent Description
Wednesday, November 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 29, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 5, 2021EXAMINER'S AMENDMENT ENTERED
Friday, March 5, 2021ASSIGNED TO LIE
Friday, March 5, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 5, 2021EXAMINERS AMENDMENT E-MAILED
Friday, March 5, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, February 26, 2021ASSIGNED TO EXAMINER
Tuesday, November 17, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, November 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 5, 2020NEW APPLICATION ENTERED